A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)

NCT00519714 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
195
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Montreal Heart Institute

Collaborators